Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.98

+1.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (6032)	3/25/2002 11:09:07 PM
From: Jibacoa	Read Replies (1) of 52153

Off topic: Miljenko: I would also let Biologists and Immunologists comment on the utility of vaccines in cancer therapy, they certainly have a much larger degree of knowledge, and I am quite aware that mine is very limited. But that doesn't prevent me from making a bet on which will be the best course a few years down the road.If I am wrong it wouldn't be the first bet I have lost and as I mentioned, it is unlikely that I still will be around "a few years more", so it seems I haven't got that much to loose.<g> As far as your inclination to bet on proteosomes, I accept it, albeit my knowledge on that field is even more limited.<g> However, I must warn you that in the unlikely case that I am still around by the time the issue is fully and satisfactorily resolved, and the proteosomes turn out to be the wining approach, it must be by itself and without the use of "Immunology" or "vaccines" .Light associated use of "hormonal" "chemo" or "radio" therapy allowed.<g> The reason for that warning is that I have seen that at S.K. they have considered the use of a "vaccine" using proteosomes.<g> ncbi.nlm.nih.gov RAGL Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next